S. Salek

发表

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications

N. Allen, J. Johns, S. Salek, 2019, Front. Pharmacol..

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward

S. Walker, S. Salek, Tariro Sithole, 2022, Frontiers in Medicine.

Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems.

N. Allen, F. Pichler, S. Salek, 2013, Health policy.

A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires.

D. Amtmann, K. Cook, R. Middleton, 2022, Multiple sclerosis and related disorders.

The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.

D. Amtmann, K. Cook, R. Middleton, 2022, Multiple sclerosis and related disorders.

Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans

N. Allen, J. Johns, S. Salek, 2019, Front. Pharmacol..

S. Salek, Hasumati Rahalkar, Alan Sheppard, 2022, Expert review of clinical pharmacology.

Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application

A. Finlay, A. Finlay, S. Salek, 2013, The British journal of dermatology.

Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities

C. Dasgupta, C. López-Morales, S. Salek, 2021, Frontiers in Medicine.

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

S. Salek, Hasumati Rahalkar, Alan Sheppard, 2021, Frontiers in Pharmacology.

Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices

S. Walker, S. Salek, Tariro Sithole, 2021, Expert review of clinical pharmacology.

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward

S. Walker, S. Salek, M. Ndomondo-Sigonda, 2022, Frontiers in Pharmacology.

Quality of Life in hematology: European Hematology Association theme of the year … and years to come

A. Hagenbeek, C. Lacombe, C. Chomienne, 2013, Haematologica.

Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey

A. Finlay, F. Ali, J. Ingram, 2021, BMJ Open.

Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists

L. Azzopardi, S. Salek, A. Serracino-Inglott, 2003 .

The feasibility, reliability and validity of the McGill Quality of Life Questionnaire-Cardiff Short Form (MQOL-CSF) in palliative care population

I. Finlay, P. L. Lua, S. Salek, 2005, Quality of Life Research.

Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial *

C. Abels, C. Apfelbacher, K. Schramm, 2020, The British journal of dermatology.

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?

S. Walker, N. Allen, L. Liberti, 2017, Front. Pharmacol..

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries

S. Walker, S. Salek, D. Darko, 2022, Frontiers in Pharmacology.

PHP26 DEVELOPMENT OF SYSTEMATIC PROCESS MAPS TO ENABLE COMPARISON BETWEEN DIFFERENT HTA AND DECISION MAKING SYSTEMS:THE FIRST STEP TO BENCHMARKING

N. Allen, F. Pichler, L. Liberti, 2010 .

A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT‐MEA): Study design and rationale

W. Almahmeed, S. Assaad-Khalil, S. Salek, 2023, Diabetes, obesity & metabolism.

Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review

D. Layton, S. Salek, S. Chan, 2023, Frontiers in Pharmacology.

Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: How this can influence practice

J. Šimko, J. Zarubova, S. Salek, 2009, Seizure.

Patient and public engagement in health-related quality of life and patient-reported outcomes research: what is important and why should we care? Findings from the first ISOQOL patient engagement symposium

S. Staniszewska, C. Norris, M. Santana, 2015, Quality of Life Research.

Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK

A. Finlay, K. Otwombe, F. Ali, 2023, BMJ Open.

Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31)

A. Kuběna, S. Salek, J. Vlček, 2007, Epilepsy & Behavior.

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement

S. Walker, S. Salek, M. Ndomondo-Sigonda, 2022, Frontiers in Pharmacology.

Evaluation of the Food and Drugs Authority, Ghana Regulatory Review Process: Challenges and Opportunities

S. Walker, S. Salek, D. Darko, 2022, Therapeutic Innovation & Regulatory Science.

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry

S. Walker, S. Salek, D. Darko, 2023, Frontiers in Pharmacology.